News
Warwick Acoustics completes £6.2m funding round
Mercia Asset Management continues to back Warwick Acoustics
Histofy and Source BioScience advancing AI-powered pathology in the UK
Histofy and Source BioScience announce strategic partnership to advance AI-powered pathology in the UK. This collaboration aims to accelerate the deployment of AI-driven diagnostics, improving accuracy, efficiency, and scalability of histopathological workflows.
University of Warwick’s secure E-voting software used in first real-world election
The University of Warwick spinout SEEV (Self-Enforcing E-Voting) technology has been successfully used in a real-world election for the first time at the UNITA Students Assembly elections
NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman
NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced that it has closed a c. £10 million (c. $13 million) financing round.
4D Medicine raises £3.4m for unique biomaterial platform
4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment.
Double win for Cytecom at Medilink Awards
Warwick spinout Cytecom wins twice at Medilink Healthcare Business Awards
Patchs Health wins again
For the second year running, Patchs Health has been recognised at the Health Tech Digital Awards.
Warwick Acoustics completes £7m funding round
The spinout company whose patented loudspeaker technology is set to revolutionise in-car audio systems has raised a further £7m in a funding round led by Mercia and including NFU Mutual and private investors.
Clinical trials success for Medherant
Warwick spinout Medherant is pleased to announce preliminary results of trials of its testosterone patch for post menopausal women.